FL56+FL57= infinite possibilities? Flagship's hybrid startup takes machine learning in drug discovery to the next level — and Covid-19 offers a quick test
On his faculty directory page at Dartmouth, Gevorg Grigoryan is unequivocal about his key fascination: “understanding the language of proteins.”
For the longtime researcher of computational protein design, it means uncovering the generalizable principles that govern the structure of biology’s fundamental building blocks. A comprehensive statistical analysis of all the molecules in the Protein Data Bank back in 2016 yielded the key insight that proteins often transfer information in certain design elements dubbed tertiary structural motifs.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 117,700+ biopharma pros reading Endpoints daily — and it's free.